← Back to headlines
Autolus Therapeutics Identified as Potential Biotech Penny Stock for 2026
An analysis suggests that Autolus Therapeutics (AUTL) could be one of the best biotech penny stocks to consider buying in 2026.
1 May, 09:23 — 1 May, 09:23
Sources
Showing 1 of 1 sources
